Skip to main content

Year: 2023

Celldex Therapeutics Announces Positive Topline Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria

-Barzolvolimab met primary endpoint with clinically meaningful and statistically significant decreases in urticaria disease activity across multiple dose groups--Mean change from baseline to week 12 in UAS7 of -23.87 in 300 mg q8w dose group and -23.02 in 150 mg q4w dose group--Barzolvolimab was generally well tolerated with a favorable safety profile--Treatment will continue to 52 weeks; results support further development of barzolvolimab in Phase 3 CSU studies-– Company to host webcast call today at 8:00 am ET- HAMPTON, N.J., Nov. 06, 2023 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today positive topline results from the Company’s Phase 2 clinical trial of barzolvolimab in patients with moderate to severe chronic spontaneous urticaria (CSU) refractory to antihistamines, including patients who...

Continue reading

Hut 8 Mining Production and Operations Update for October 2023

At 9,113 BTC, Hut 8 continues to have one of the largest self-mined Bitcoin reserves of any publicly traded company 112 Bitcoin mined in October TORONTO, Nov. 06, 2023 (GLOBE NEWSWIRE) —  Hut 8 Mining Corp. (Nasdaq: HUT) (TSX: HUT), (“Hut 8” or the “Company”) one of North America’s largest, innovation-focused digital asset mining pioneers and high performance computing infrastructure provider, mined 112 Bitcoin in October 2023. Production highlights for October 2023:112 Bitcoin were generated, resulting in an average production rate of approximately 3.6 Bitcoin per day 365 Bitcoin – 66 Bitcoin produced in July, all of August’s and September’s production, and 85 Bitcoin produced in October – were sold during the month for proceeds totalling CAD$14.6 million (average proceeds per Bitcoin of approximately CAD$39,980) Total...

Continue reading

Freshpet, Inc. Reports Third Quarter 2023 Financial Results

Raises 2023 Adjusted EBITDA and net sales guidanceVolume and household penetration growth are strong and acceleratingStrong execution on input costs, logistics and quality continue to drive margin improvement SECAUCUS, N.J., Nov. 06, 2023 (GLOBE NEWSWIRE) — Freshpet, Inc. (“Freshpet” or the “Company”) (Nasdaq: FRPT) today reported financial results for its third quarter ended September 30, 2023. Third Quarter 2023 Financial Highlights Compared to Prior Year PeriodNet sales of $200.6 million, an increase of 32.6%. Net loss of $7.2 million, compared with prior year net loss of $18.4 million. Adjusted EBITDA of $23.2 million, compared to prior year of $3.5 million.1First Nine Months of 2023 Financial Highlights Compared to Prior Year PeriodNet sales of $551.5 million, an increase of 28.4%. Net loss of $48.9 million, compared...

Continue reading

Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business Update

~ PEDMARK® Net Product Revenue of $6.5 Million, a 96% Increase Compared to Second Quarter ~ ~ Strong Commercial Uptake Underscoring Significant Unmet Medical Need ~ ~ Received Approval in October 2023 by the Medicines and Healthcare Products Regulatory Agency (MHRA) in the U.K. for PEDMARQSI ~ ~ Management to Host Conference Call Today at 8:30 a.m. ET ~ RESEARCH TRIANGLE PARK, N.C., Nov. 06, 2023 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today reported its financial results for the third quarter ended September 30, 2023 and provided a business update. “We continued to see strong commercial performance with PEDMARK® in the third quarter demonstrated by net product revenue of $6.5 million representing 96% quarter over quarter growth. PEDMARK® addresses...

Continue reading

Sodexo – Monthly disclosure on share capital and voting rights October 31, 2023

Regulated informationIssy-les-Moulineaux, November 6th, 2023 Monthly disclosure on share capital and voting rightsPursuant to Article L.233-8-II of the French Commercial Code and Article 223-16 of the General Regulations of the Autorités des Marchés Financiers Registered name of the issuer: SODEXO255, quai de la Bataille de Stalingrad – 92130 ISSY-LES-MOULINEAUXDate Total number of shares Actual voting rights * Theoretical voting rights **October 31, 2023147,454,887215,985,728217,064,246* Actual voting rights: all of the Company shares have the same voting rights, except for treasury shares which do not have voting rights and registered shares held for more than four years, which have double voting rights. ** Theoretical voting rights: the number of theoretical voting rights is calculated based on the shares having...

Continue reading

Inside Information: Sanoma’s President and CEO Susan Duinhoven to step down during the first half of 2024

Sanoma Corporation, Inside Information, 6 November 2023 at 12:00 EET Inside Information: Sanoma’s President and CEO Susan Duinhoven to step down during the first half of 2024 Sanoma Corporation’s President and CEO Susan Duinhoven has informed Sanoma’s Board of Directors that she will step down from the role of President and CEO during the first half of 2024. The Board has initiated a search for her successor. Susan Duinhoven was appointed President and CEO of Sanoma in October 2015. She is committed to remaining fully operational as CEO until her successor has started and ensuring a solid transition after that. “Susan has done outstanding job in transforming Sanoma from a cross-media company operating in multiple countries to the leading European K12 learning company. At the same time, she has focused intensively on strengthening...

Continue reading

PubMatic is First Sell-Side Technology Provider to Offer Powerful Experian Commerce Data in Both the US and UK

LONDON, Nov. 06, 2023 (GLOBE NEWSWIRE) — PubMatic, (Nasdaq: PUBM), an independent technology company delivering digital advertising’s supply chain of the future, today announced a groundbreaking data collaboration with Experian, the world’s leading global information services company. The collaboration marks a major milestone in the advertising industry, as PubMatic becomes the first sell-side technology provider of Experian marketing data in both the US and UK, providing its clients with unique household-level commerce media targeting capabilities. Experian’s syndicated audiences encompass a wealth of information including consumer demographics, spending models, property data, and automotive audiences, complemented by the extensive, cross-channel insights offered by Experian’s Mosaic® segments. These unique and privacy-centric...

Continue reading

Sydbank share buyback programme: transactions in week 44

        Company Announcement No 37/2023Peberlyk 46200 AabenraaDenmark Tel +45 74 37 37 37Fax +45 74 37 35 36 Sydbank A/SCVR No DK 12626509, Aabenraasydbank.dk6 November 2023  Dear Sirs Sydbank share buyback programme: transactions in week 44On 6 July 2023 Sydbank announced a share buyback programme of DKK 600m. The share buyback programme commenced on 10 July 2023 and will be completed by 31 January 2024. The purpose of the share buyback programme is to reduce the share capital of Sydbank and the programme is executed in compliance with the provisions of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 and Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, collectively referred to as the Safe Harbour rules. The following transactions have been made under the share buyback...

Continue reading

INVITATION TO CONFERENCE CALL FOR DFDS’ REPORT FOR Q3 2023

INVESTOR NEWS no. 36 – 6 November 2023 DFDS expects to publish the report for Q3 2023 on 15 November 2023 at around 07:30 CET. Torben Carlsen, CEO, and Karina Deacon, CFO, will present the report on a live conference call. The presentation will be followed by a Q&A session. Investors, analysts and other interested parties are invited to take part.   Conference call Date:        15 November 2023 Time:        10:00 CET Registration:        Register ahead of the call via this link. Access code is mailed after registration.   Please register in good time for the conference call. Live-streaming of the conference call is available from this link.   Contact Søren Brøndholt Nielsen, IR +45 33 42 33 59   Capital markets day 13 DecDFDS is hosting a CMD on 13 December 2023. More information and sign-up is available here.   About...

Continue reading

INVITATION TO CONFERENCE CALL FOR DFDS’ REPORT FOR Q3 2023

INVESTOR NEWS no. 36 – 6 November 2023 DFDS expects to publish the report for Q3 2023 on 15 November 2023 at around 07:30 CET. Torben Carlsen, CEO, and Karina Deacon, CFO, will present the report on a live conference call. The presentation will be followed by a Q&A session. Investors, analysts and other interested parties are invited to take part.Conference call Date:        15 November 2023 Time:        10:00 CET Registration:        Register ahead of the call via this link. Access code is mailedafter registration.Please register in good time for the conference call. Live-streaming of the conference call is available from this link.Contact  Søren Brøndholt Nielsen, IR +45 33 42 33 59Capital markets day 13 DecDFDS is hosting a CMD on 13 December 2023. More information and sign-up is available here.About DFDS We...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.